As the first COVID-19 vaccines are rolled out around the world, HIV/AIDS experts and advocates have sought to reassure those ...

Q3 2025 Management View CEO Marianne De Backer highlighted the completion of enrollment in ECLIPSE 1, Vir’s first ...

With his spectacular goal to make it 1-2, Jean-Luc Dompé provided one of the few positive HSV stories of the past weekend. In ...

India is witnessing a sharp rise in infectious diseases, with one in nine tests coming positive for dengue and influenza A, ...

1:2 in Leipzig, 0:1 against Wolfsburg, and now a 1:4 in Cologne: HSV has been unable to find their footing since the end of the October international break, at least in terms of sporting success in ...

A recent ICMR study has uncovered that 11.1% of patients tested in India are infected with significant pathogens, marking a ...

Following the recently announced positive Phase 3 topline results ... About Pritelivir Pritelivir, a novel helicase-primase inhibitor developed by Aicuris, targets both HSV-1 and HSV-2. These viruses ...

Merck (NYSE:MRK) reported positive results from late-stage studies on a new oral treatment which combines two drugs, doravirine and islatravir, for adults with HIV-1. The studies looked at adults ...

After the FDA revoked Sarepta Therapeutics’ platform designation in July, Krystal Biotech is “poised to be the first major beneficiary” of this program, according to analysts at William Blair. The FDA ...

Eli Lilly released the results of two new Phase 3 trials of an experimental GLP-1 pill that the company says could become a “foundational treatment” for type 2 diabetes. The medicine, orforglipron, ...

Pfizer's oncology portfolio has produced a second positive phase 3 trial in HER2-positive breast cancer in the span of about a year. This time, the drug that delivered the positive readout is Tukysa, ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Hezbollah’s al-Mahdi Scouts hold pictures of ...